Causes and treatment of periorbital hyperchromia
DOI:
https://doi.org/10.5327/Z1984-4840201623330Keywords:
skin age, eyelids, hyperpigmentation, edema, cosmetic techniquesAbstract
The periorbital region is one of the first areas to demonstrate signs of aging such as wrinkling, skin laxity and periorbital hyperpigmentation (HPO). The HPO interferes in the facial appearance resulting on a tired, sadness or hangover aspects. It has a complex etiopathogenesis with factors that could be by primary or secondary cause. The genetic factors are stated as a primary cause and the environmental factors are stated as a secondary cause. In that way, there are many examples of environmental factors such as excess of sun exposition, post inflammatory hyper pigmentation, excess of subcutaneous vascularization, hyper transparency of the skin, periorbital edema, and fat herniation eyelid. The clinical severity of the condition varies and normally the hyper pigmentation is present bilaterally and symmetrically around the eye region. The main objective of this study was to develop and evaluate the causes and etiological factors, and to describe the possible treatments available in the current literature. It was utilized 26 scientific papers on the following subjects: anatomy, etiology, causes and treatments. Owing to the information scarcity about its etiology, as well as its consensual treatment, it is necessary an adequate clinical examination in order to provide directions to the conduct. There are several suggestions for HPO treatment described: peeling, fillers, autologous fat fillers, cosmetic use, injection of platelet rich plasma (PRP), and carboxytherapy.Downloads
Metrics
References
Roberts WE. Periorbital hyperpigmentation: review of etiology, medical evaluation, and aesthetic treatment. J Drugs Dermatol. 2014;13(4):472-82.
Bucay VW, Day D. Adjunctive skin care of the brow and periorbital region. Clin Plast Surg. 2013;40(1):225-36.
Alsaad SM, Mikhail M. Periocular hyperpigmentation: a review of etiology and current treatment options. J Drugs Dermatol. 2013;12(2):154-7.
Verschoore M, Gupta S, Sharma V, Ortonne JP. Determination of melanin and haemoglobin in the skin of idiopathic cutaneous hyperchromia of the orbital region (ICHOR): a study of Indian patients. J Cutan Aesthet Surg. 2012;5(3):176-82.
Freitag FM, Cestari TF. What causes dark circles under the eyes? J Cosmet Dermatol. 2007;6(3):211-5.
Roh MR, Chung KY. Infraorbital dark circles: definition, causes, and treatment options. Dermatol Surg. 2009;35(8):1163-71.
Palermo EC. Anatomia da região periorbital. Surg Cosmet Dermatol. 2013;5(3):245-56.
Friedmann DP, Goldman MP. Dark circles: etiology and management options. Clin Plast Surg. 2015;42(1):33-50.
Souza DCM, Ludtke C, Souza ERM, Rocha NW, Weber MB, Manzoni APD, et al. Comparação entre ácido tioglicólico 2.5%, hidroquinona 2%, haloxyl 2% e peeling de ácido glicólico 10% no tratamento da hiperpigmentação periorbital. Surg Cosmet Dermatol. 2013;5(1):46-51.
Kurban RS, Bhawan J. Histologic changes in skin associated with aging. J Dermatol Surg Oncol. 1990;16(10):908-14.
Kikuchi K, Masuda Y, Hirao T. Imaging of hemoglobin oxygen saturation ratio in the face by spectral camera and its application to evaluate dark circles. Skin Res Technol. 2013;19(4):499-507.
Graziosi AC, Quaresma MR, Michalany NS, Ferreira LM. Cutaneous idiopathic hyperchromia of the orbital region (CIHOR): a histopathological study. Aesthetic Plast Surg. 2013;37(2):434-8.
Watanabe S, Nakai K, Ohnishi T. Condition known as “dark rings under the eyes” in the Japanese population is a kind of dermal melanocytosis which can be successfully treated by Q-switched ruby laser. Dermatol Surg. 2006;32(6):785-9.
Berson DS, Cohen JL, Rendon MI, Roberts WE, Starker I, Wang B. Clinical role and application of superficial chemical peels in today’s practice. J Drugs Dermatol. 2009;8(9):803-11.
Vavouli C, Katsambas A, Gregoriou S, Teodor A, Salavastru C, Alexandru A, et al. Chemical peeling with trichloroacetic acid and lactic acid for infraorbital dark circles. J Cosmet Dermatol. 2013;12(3):204-9.
Kede MPV, Sabatovich O. Dermatologia estética. 2ª ed. São Paulo: Atheneu; 2009. p. 104-4,767-19.
Kadunc BV, Palermo E, Addor FAS, Metsavaht L, Mattos R, Bezerra SMC. Tratado de cirurgia dermatológica, cosmiatria e laser da Sociedade Brasileira de Dermatologia. São Paulo: Elsevier; 2013. p. 224-18, 412-35, 759-71.
Alster T, Bellew SG. Improvement of dermatochalasis and periorbital rhytides with a high-energy pulsed CO2 laser: a retrospective study. Dermatol Surg. 2004;30(4 Pt 1):483-7; discussion 487.
Cymbalista NC, Osorio NEGS, Torezan LAR, Mattos RA. Treatment of hyperpigmentation peripalpebral with Q-switched ruby laser x intense pulsed light. Lasers Surg Med. 2002;30(514):58-87.
Cymbalista NC, Oliveira ZNP. Treatment of idiopathic cutaneous hyperchromia of the orbital region (ICHOR) with intense pulsed light. Dermatol Surg. 2006;32(6):773-83; discussion 783-4.
Teixeira V, Badin AZD, Ottoboni E, Bailak M, Salles Junior GS, Vieira JC, et al. Tratamento da hipercromia cutânea idiopática da região orbital com Erbium Laser: uma avaliação retrospectiva. Arq Catarin Med. 2007;36(Suppl 1):76-9.
Prignano F, Ortonne JP, Buggiani G, Lotti T. Therapeutical approaches in melasma. Dermatol Clin. 2007;25(3):337-42.
Mitsuishi T, Shimoda T, Mitsui Y, Kuriyama Y, Kawana S. The effects of topical application of phytonadione, retinol and vitamins C and E on infraorbital dark circles and wrinkles of the lower eyelids. J Cosmetic Dermatol. 2004;3(2):73-5.
Maio M. Tratado de medicina estética. Rio de Janeiro: Roca; 2011. p. 94.
Paolo F, Nefer F, Paola P, Nicolo S. Periorbital area rejuvenation using carbon dioxide therapy. J Cosmet Dermatol. 2012;11(3):223-8.
Finn JC, Cox S. Fillers in the periorbital complex. Facial Plast Surg Clin North Am. 2007;15(1):123-32.
Roh MR, Kim TK, Chung KY. Treatment of infraorbital dark circles by autologous fat transplantation: a pilot study. Br J Dermatol. 2009;160(5):1022-5.
Wang HL, Avila G. Platelet rich plasma: myth or reality? Eur J Dent. 2007;1(4):192-4.
Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg. 2004;62(4):489-96.
Mehryan P, Zartab H, Rajabi A, Pazhoohi N, Firooz A. Assessment of efficacy of platelet-rich plasma (PRP) on infraorbital dark circles and crow’s feet wrinkles. J Cosmet Dermatol. 2014;13(1):72-8.
Downloads
Published
How to Cite
Issue
Section
License
Os autores no momento da submissão transferem os direitos autorais, assim, os manuscritos publicados passam a ser propriedade da revista.
O conteúdo do periódico está licenciado sob uma Licença Creative Commons 4.0, esta licença permite o livre acesso imediato ao trabalho e que qualquer usuário leia, baixe, copie, distribua, imprima, pesquise ou vincule aos textos completos dos artigos, rastreando-os para indexação, passá-los como dados para o software, ou usá-los para qualquer outra finalidade legal.